What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients? episode artwork

EPISODE · Feb 22, 2022 · 45 MIN

What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients?

from Bladder Cancer Matters · host Bladder Cancer Advocacy Network

In Episode 22 of Bladder Cancer Matters, host Rick Bangs talks with Drs. Phil Abbosh and Max Kates about bladder cancer biomarkers.  Dr. Abbosh is a urologic oncologist at the Fox Chase Cancer Center in Philadelphia. Dr. Kates is an assistant professor of urology and oncology with the Brady Urological Institute at Johns Hopkins in Baltimore. Rick and Drs. Abbosh and Kates talk about what biomarkers are and how they are relevant to bladder cancer. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition like bladder cancer. Click here to read the transcript.

Episode metadata supplied by the publisher feed · Published Feb 22, 2022

Embed this episode

Ready to play

What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients?

0:00 45:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Bladder Cancer Matters?

This episode is 45 minutes long.

When was this Bladder Cancer Matters episode published?

This episode was published on February 22, 2022.

Can I download this Bladder Cancer Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!